Literature DB >> 3413200

Nicotine gum: chew rate, subjective effects and plasma nicotine.

R Nemeth-Coslett1, N L Benowitz, N Robinson, J E Henningfield.   

Abstract

Two studies were conducted to assess the effects of varying the rate at which single pieces of nicotine gum (4 mg) were chewed. In each study, six cigarette-deprived volunteers were tested during four sessions. In each session, they were required to chew the gum for 10 min at varying rates; a variety of self-report and physiologic responses were recorded before and after chewing. All chewed gum was analyzed for amount of nicotine extracted, and blood samples were collected for nicotine analysis. Additionally, in Experiment 2, a measure of masticatory pressure was employed to assess the intensity of chewing and to empirically verify the number of chews. In both studies, we found a weak, but direct, relation between chew rate and the amount of extracted nicotine. Experiment 2 revealed a probable cause of the weaker than expected "dose-effect" function: subjects showed compensatory changes in behavior by chewing slower than instructed in the high rate conditions, and by chewing faster than instructed in the low rate conditions. Thus, despite instructions to vary chew rates across an 8-fold range, actual chew rate varied by only 2.2-fold. Intensity of chewing remained constant across conditions. Taken together, the findings suggest that rate of chewing nicotine gum can make a difference in the amount of nicotine extracted from the gum; however, compensatory changes in chew rate may attenuate attempts to systematically vary nicotine dose in this manner.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3413200     DOI: 10.1016/0091-3057(88)90197-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Nicotine delivery and pharmacologic response from Verve, an oral nicotine delivery product.

Authors:  Bartosz Koszowski; Lauren C Viray; Stephen B Stanfill; Joseph G Lisko; Zach R Rosenberry; Jennifer L Potts; Wallace B Pickworth
Journal:  Pharmacol Biochem Behav       Date:  2015-06-19       Impact factor: 3.533

2.  Subjective effects of the nicotine lozenge: assessment of abuse liability.

Authors:  Elisabeth J Houtsmuller; Jack E Henningfield; Maxine L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  2003-03-04       Impact factor: 4.530

Review 3.  [Smoking cessation with nicotine replacement therapy (NRT) - a scientific update].

Authors:  Karl-Heinz Mulzer; Alfred Lichtenschopf; Irmgard Homeier; Ernest Groman
Journal:  Wien Med Wochenschr       Date:  2009

4.  Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.

Authors:  Jianmin Liu; Jingzhu Wang; Andrea Vansickel; Jeffery Edmiston; Donald Graff; Mohamadi Sarkar
Journal:  Clin Pharmacol Drug Dev       Date:  2021-01-27

5.  Medicated Chewing Gums: Recent Patents and Patented Technology Platforms.

Authors:  Prerna Kaushik; Deepak Kaushik
Journal:  Recent Pat Drug Deliv Formul       Date:  2019

6.  Human brain functional network changes associated with enhanced and impaired attentional task performance.

Authors:  Carsten Giessing; Christiane M Thiel; Aaron F Alexander-Bloch; Ameera X Patel; Edward T Bullmore
Journal:  J Neurosci       Date:  2013-04-03       Impact factor: 6.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.